Wynzora

Wynzora combines betamethasone and calcipotriol for topical treatment of plaque psoriasis. This corticosteroid and vitamin D3 analog work together to reduce inflammation and skin cell overgrowth. Wynzora is applied directly to affected skin areas as prescribed.

Wynzora is used to treat plaque psoriasis, a chronic skin condition causing raised, red patches with silvery scales. It helps reduce inflammation, itching, and scaling while slowing skin cell growth. Wynzora is designed for adults with mild to moderate plaque psoriasis on the body and scalp. It is not intended for use on the face, groin, or underarms.

Wynzora works by combining the anti-inflammatory effects of betamethasone with the skin cell regulation of calcipotriol. Users often report reduced redness and scaling within the first few weeks of consistent use. Some may experience temporary skin dryness or mild irritation at the application site.

Wynzora is for external use only and should not be applied to broken or infected skin. Avoid contact with eyes, mouth, or mucous membranes. Wash hands thoroughly after application unless treating hand areas. Do not use occlusive dressings unless directed by a healthcare provider. Keep out of reach of children.

Avoid using Wynzora with other strong corticosteroids or vitamin D derivatives to prevent excessive exposure. Inform your healthcare provider about all medications, including over-the-counter products and supplements. Alcohol-based products may increase skin dryness. Use caution when combining with phototherapy.